Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$82.93 -0.99 (-1.18%)
At close: Oct 2, 2026 · 4:00 PM EDT

Mirum Pharmaceuticals (MIRM) Return on Assets [ROA] (2019 - 2026)

Updated

Mirum Pharmaceuticals' Return on Assets [ROA] was -88.87% in Q2 2026, down 80.60 percentage points from -8.27% a year earlier but up 3.28 percentage points from the prior quarter.

Analysis

Mirum Pharmaceuticals (MIRM) Return on Assets [ROA] (2019 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Mirum Pharmaceuticals came in at -3.09%, up 10.26 percentage points from FY2024.

  • Return on Assets [ROA] has now increased for three consecutive years, with a five-year change of +50.20 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -13.35% in FY2024 (+19.35 pp), -32.70% in FY2023 (+9.20 pp), -41.90% in FY2022 (-10.53 pp) and -31.37% in FY2021 (+21.92 pp).
  • Quarterly Return on Assets [ROA] has moved between -92.15% (Q1 2026) and -2.87% (Q4 2025) over five years.
  • Compared with a year earlier, Return on Assets [ROA] was higher in six of the last eight quarters, with an average year-over-year change of -11.64 percentage points.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q3 2022 (a gain of 61.43 percentage points); the worst was Q1 2026 (a drop of 80.79 percentage points).
  • Per Business Quant data, MIRM's Return on Assets [ROA] in the three quarters before Q2 2026 was -92.15% (Q1 2026), -2.87% (Q4 2025) and -5.48% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Mirum Pharmaceuticals 5.37 Bn 3.79 Bn 145.90 Mn -88.87%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -88.87%
Mar 31, 2026 -92.15%
Dec 31, 2025 -2.87%
Sep 30, 2025 -5.48%
Jun 30, 2025 -8.27%
Mar 31, 2025 -11.37%
Dec 31, 2024 -13.14%
Sep 30, 2024 -15.02%
Jun 30, 2024 -16.63%
Mar 31, 2024 -24.42%
Dec 31, 2023 -25.19%
Sep 30, 2023 -30.01%
Jun 30, 2023 -45.37%
Mar 31, 2023 -37.64%
Dec 31, 2022 -37.83%
Sep 30, 2022 -12.60%
Jun 30, 2022 -18.45%
Mar 31, 2022 -24.46%
Dec 31, 2021 -31.70%
Sep 30, 2021 -74.04%
API Access

Mirum Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=MIRM&period=max&api_key=YOUR_API_KEY